Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. White House Pharmacy Inc. dba San Jose Compounding Pharmacy
483
•White House Pharmacy Inc. dba San Jose Compounding Pharmacy•September 14, 2018

White House Pharmacy Inc. dba San Jose Compounding Pharmacy – FDA 483, Sep 14, 2018

Record Details

The FDA Form 483 documents observations from an inspection, highlighting deficiencies in drug manufacturing practices. The facility produced beta-lactam drugs, highly potent drugs, and hazardous drugs without adequate containment, segregation, and cleaning to prevent cross-contamination.

Specifically, beta-lactam products were produced on the same day and in the same room (Lab Room) as non-beta lactam products, on a shared table within two feet. The cleaning agent used for work surfaces, (b)(4), and for dirty equipment, (b)(4) dish soap and water, were ineffective in deactivating beta-lactams.

Highly potent drugs, including Hydrocodone Bitartrate 10 MG capsules and Fentanyl Sorbitol Base (Veggie) 500 MCG Lollipops, were produced in the Lab Room on a shared table with limited space, alongside other patient-specific prescriptions. Cleaning agents (b)(4) for surfaces and (b)(4) for equipment were ineffective in removing highly potent residues.

Hazardous drugs, such as Testosterone and Progesterone, were produced in the Hazardous Room concurrently with other hazardous products. The firm's SOP 3.050, "Cleaning and Maintenance of the Non-Sterile Compounding Area," specifies cleaning solutions (b)(4) or (b)(4) and decontaminating solution (b)(4), which were found ineffective for deactivating hazardous drugs.

Additionally, the firm

Company
White House Pharmacy Inc. dba San Jose Compounding Pharmacy
Inspection date
September 14, 2018
Product type
Drugs
Office
San Francisco District Office
Person
  • Kristin M. Abaonza
View Company Profile

ID · 94a50a21-88f5-4882-82ce-d5ddb0a0d622

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore White House Pharmacy Inc. dba San Jose Compounding Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.